Cell Therapy & Immunotherapy

In order to meet requirements of both, individualized immunotherapeutic concepts and cellular therapy approaches requiring hundreds of peptides, JPT has established an enhanced peptide production environment that goes beyond ISO 9001:2015 regulations for more stringent product requirements. The resulting ISO PLUS and Clinical Grade Peptides and peptide pools can be applied in collaborations and contract research aiming for the development of new therapy and vaccine concepts targeting indications ranging from cancer and infectious diseases to autoimmune and allergies.

Project Examples

Development of individualized therapy concepts
Adoptive cell transfer
Dendritic cell-based therapies
Neo-epitope based peptide vaccination strategies

Our Capabilities

Traceability of workflows
Comprehensive analytical capabilities
Documentation acc. to regulations
Peptide selection and design